Taken together, our findings support that the Kmt2a+/LSL mouse model recapitulates core human WDSTS disease phenotypes and allows for quantitative measurement of a number of metrics related to the neurological phenotype that can be used to investigate the in utero malleability. Here, KMT2A is linked to Wiedemann-Steiner syndrome.